Featured Research

from universities, journals, and other organizations

Blood Is Less Sticky With Estrogen Replacement Therapy

Date:
December 11, 1998
Source:
American Heart Association
Summary:
By helping keep their blood less sticky, or viscous, hormone replacement therapy (HRT) may help women lower their risk of heart disease, according to a study in today's Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

DALLAS, Dec. 11 -- By helping keep their blood less sticky, or viscous, hormone replacement therapy (HRT) may help women lower their risk of heart disease, according to a study in today's Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

Related Articles


Robert Rosenson, M.D., director of the Preventive Cardiology Center, Rush-Presbyterian-St. Luke's Medical Center, and collaborators at the University of Michigan at Ann Arbor, measured the viscosity of plasma -- the fluid component of blood -- in 23 women. Viscosity is the friction of a fluid that makes it resist flowing. Water has a low viscosity while molasses is highly viscous.

"Plasma viscosity is an important predictor of initial and recurrent heart attack and stroke," says Rosenson. "Studies have suggested viscosity to be as important a predictor of heart disease risk as smoking, diabetes, cholesterol or blood pressure, but this is the first study to evaluate the influence of HRT on plasma viscosity."

The study found that HRT lowered a woman's blood viscosity. This effect may be a new mechanism for the cardiovascular protection received by women taking HRT, says Rosenson.

Researchers divided the 23 women in the study into three groups. Seven women received estrogen plus progesterone therapy, eight women took estrogen alone, and the remaining eight received an inactive pill called a placebo.

"At the end of 12 weeks, viscosity in both groups receiving estrogen therapy decreased by about four percent. Based on other studies we would equate this change in viscosity to a decrease in heart disease risk by about 20 percent," says Rosenson.

Rosenson also notes that blood levels of low-density lipoprotein (LDL) or the 'bad' cholesterol of the women in both estrogen groups fell by 29 percent, and fibrinogen levels decreased by 14 percent.

Previous studies have indicated that HRT lowers blood levels of fibrinogen, a clotting factor, and LDL cholesterol says Rosenson. These factors may contribute to plasma viscosity because higher levels of fibrinogen and LDL make blood stickier, he adds.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Blood Is Less Sticky With Estrogen Replacement Therapy." ScienceDaily. ScienceDaily, 11 December 1998. <www.sciencedaily.com/releases/1998/12/981211083757.htm>.
American Heart Association. (1998, December 11). Blood Is Less Sticky With Estrogen Replacement Therapy. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/1998/12/981211083757.htm
American Heart Association. "Blood Is Less Sticky With Estrogen Replacement Therapy." ScienceDaily. www.sciencedaily.com/releases/1998/12/981211083757.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins